FLEX PHARMA INC's ticker is FLKS and the CUSIP is 33938A105. A total of 22 filers reported holding FLEX PHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $12,000 | +50.0% | 21,462 | 0.0% | 0.00% | – |
| Q1 2019 | $8,000 | +14.3% | 21,462 | 0.0% | 0.00% | – |
| Q4 2018 | $7,000 | -30.0% | 21,462 | -6.1% | 0.00% | – |
| Q3 2018 | $10,000 | -54.5% | 22,862 | 0.0% | 0.00% | – |
| Q2 2018 | $22,000 | -80.7% | 22,862 | 0.0% | 0.00% | – |
| Q1 2018 | $114,000 | +42.5% | 22,862 | 0.0% | 0.00% | – |
| Q4 2017 | $80,000 | +17.6% | 22,862 | +14.3% | 0.00% | – |
| Q3 2017 | $68,000 | -82.4% | 20,006 | -80.0% | 0.00% | – |
| Q2 2017 | $386,000 | -24.6% | 100,161 | -13.9% | 0.00% | – |
| Q1 2017 | $512,000 | -15.4% | 116,295 | +1.5% | 0.00% | – |
| Q4 2016 | $605,000 | -55.8% | 114,624 | -1.4% | 0.00% | – |
| Q3 2016 | $1,369,000 | +13.3% | 116,240 | -1.8% | 0.00% | – |
| Q2 2016 | $1,208,000 | +56.7% | 118,326 | +68.6% | 0.00% | – |
| Q1 2016 | $771,000 | -10.5% | 70,199 | +1.5% | 0.00% | – |
| Q4 2015 | $861,000 | +6.4% | 69,165 | +2.7% | 0.00% | – |
| Q3 2015 | $809,000 | -16.7% | 67,361 | +19.3% | 0.00% | – |
| Q2 2015 | $971,000 | +273.5% | 56,459 | +325.2% | 0.00% | – |
| Q1 2015 | $260,000 | – | 13,279 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 908,691 | $15,629,000 | 5.21% |
| ACUTA CAPITAL PARTNERS, LLC | 88,716 | $1,526,000 | 0.94% |
| Tekla Capital Management LLC | 232,600 | $4,001,000 | 0.14% |
| THOMPSON DAVIS & CO., INC. | 6,625 | $114,000 | 0.13% |
| Lombard Odier Asset Management (USA) Corp | 103,318 | $1,777,000 | 0.13% |
| Abingworth LLP | 10,000 | $172,000 | 0.08% |
| WALL STREET ASSOCIATES | 40,000 | $688,000 | 0.06% |
| AWM Investment Company, Inc. | 25,000 | $430,000 | 0.06% |
| Nicholas Investment Partners, LP | 46,474 | $799,000 | 0.05% |
| Visium Asset Management, LP | 119,900 | $2,062,000 | 0.03% |